These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1606526)

  • 1. The clinical efficacy of IVGG in Kawasaki disease.
    Rowley AH; Shulman ST
    Clin Rev Allergy; 1992; 10(1-2):81-91. PubMed ID: 1606526
    [No Abstract]   [Full Text] [Related]  

  • 2. Gamma globulin re-treatment in Kawasaki disease.
    Sundel RP; Burns JC; Baker A; Beiser AS; Newburger JW
    J Pediatr; 1993 Oct; 123(4):657-9. PubMed ID: 8410524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The many faces of Kawasaki syndrome.
    Leung DY; Meissner HC
    Hosp Pract (1995); 2000 Jan; 35(1):77-81, 85-6, 91-4. PubMed ID: 10645991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous gamma-globulin for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
    Terai M; Shulman ST
    J Pediatr; 1997 Dec; 131(6):888-93. PubMed ID: 9427895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey.
    Yanagawa H; Yashiro M; Nakamura Y; Sakata K; Kawasaki T
    Acta Paediatr; 1995 Jul; 84(7):765-8. PubMed ID: 7549294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical manifestations and effects of IVGG in patients with Kawasaki disease].
    Hwang KP; Wu JR; Huang LY; Liou CC; Huang TY
    Kaohsiung J Med Sci; 1996 Mar; 12(3):159-66. PubMed ID: 8709183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous gammaglobulin for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Lancet; 1984 Nov; 2(8411):1055-8. PubMed ID: 6209513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative safety and efficacy of two immune globulin products in Kawasaki disease.
    Rosenfeld EA; Shulman ST; Corydon KE; Mason W; Takahashi M; Kuroda C
    J Pediatr; 1995 Jun; 126(6):1000-3. PubMed ID: 7776074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVIG, aspirin, and Kawasaki disease.
    Morgan GJ; MacLeod C; Jenkins J; Stewart C; Craig B
    J Pediatr; 2003 Aug; 143(2):280-1; author reply 281. PubMed ID: 12970651
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
    Hsu CH; Chen MR; Hwang FY; Kao HA; Hung HY; Hsu CH
    Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Kawasaki disease in the British Isles.
    Dhillon R; Newton L; Rudd PT; Hall SM
    Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Abinun M; Cant AJ
    Lancet; 1994 Jan; 343(8892):300. PubMed ID: 7905129
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of Kawasaki disease.
    Sagraves R
    J Pediatr Health Care; 1993; 7(6):278-82. PubMed ID: 8106928
    [No Abstract]   [Full Text] [Related]  

  • 17. Kawasaki disease. Kawasaki disease?
    Moss KW
    Alaska Med; 2000; 42(2):30-6. PubMed ID: 10916855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S; Matsubara T; Umezawa Y; Motohashi T; Ino T; Yabuta K
    Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease.
    Bavdekar SB; Vaswani LK; Shalini H; Chandu KV; Gaikwad R; Kamat JR
    J Indian Med Assoc; 1998 Aug; 96(8):257-8. PubMed ID: 9830299
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of immunoglobulin retreatment in Kawasaki disease.
    Falcini F; Ermini M; Trapani S; Taccetti G
    J Pediatr; 1994 Oct; 125(4):672-3. PubMed ID: 7931898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.